Immunology

J. Bruix, J.M. Barrera, X. Calvet, G. Ercilla, et al., "Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis," Lancet, 2, 1004-6, 28 October 1989. Jordi Bruix (Liver Unit, Hospital Clinic i Provincial, Barcelona, Spain): "Hepatocellular carcinoma (HCC) is a neoplasm that usually arises on a cirrhotic liver. In areas with high incidence of hepatitis B virus (HBV) infection, HCC seems to be strongly related to this virus. In low HBV

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

J. Bruix, J.M. Barrera, X. Calvet, G. Ercilla, et al., "Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis," Lancet, 2, 1004-6, 28 October 1989.

Jordi Bruix (Liver Unit, Hospital Clinic i Provincial, Barcelona, Spain): "Hepatocellular carcinoma (HCC) is a neoplasm that usually arises on a cirrhotic liver. In areas with high incidence of hepatitis B virus (HBV) infection, HCC seems to be strongly related to this virus. In low HBV incidence areas, however, the relation of HBV to HCC is not so clear. In Europe, the etiology of the underlying cirrhosis is less frequently related to HBV, and, therefore, patients are diagnosed with HCC-complicating cryptogenic or alcoholic cirrhosis. The availability of a test to determine the presence of antibodies against the so-called C virus (HCV) allowed us to investigate the possible association of this newly identified virus and the presence of HCC. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies